Why Cameroon Needs a Homegrown Health Tech Revolution — And What It Looks Like

Introduction: Borrowed Technology Rarely Fits

For decades, Cameroon's approach to healthcare technology has largely followed a familiar pattern: identify a problem, find an international organisation willing to fund a solution, import a technology platform developed elsewhere, implement it through a time-limited project, and hope it survives when the funding ends.

This approach has produced some genuine progress. Electronic health records for HIV patients. National disease surveillance via DHIS2. Telemedicine pilots in rural areas. These are real achievements, and the organisations and individuals behind them deserve credit.

But the approach has fundamental limitations that are becoming impossible to ignore. Borrowed technology — designed for other contexts, maintained by organisations with other priorities, and sustainable only as long as external funding continues — cannot transform a health system. It can improve specific programmes. It cannot build the comprehensive, integrated, self-sustaining digital health infrastructure that Cameroon needs.

That requires something different: a homegrown health tech revolution. Technology built by Cameroonians, for Cameroonian realities, owned by Cameroonian institutions, and sustained by the commercial value it creates. This article makes the case for why this matters — and what it looks like in practice.

The Limits of Imported Health Technology

Every year, international organisations and bilateral donors spend hundreds of millions of dollars on health technology in sub-Saharan Africa. Much of this spending goes on software — electronic medical record systems, health information platforms, telemedicine tools, supply chain management software — developed primarily in the United States, Europe, or, increasingly, India.

This software is not bad. In its original contexts — well-resourced hospitals with reliable electricity and internet, literate patient populations, established insurance systems, and large IT departments — it works well.

The problem is that Cameroonian health facilities do not look like American hospitals or European clinics. The gap between the context the software was designed for and the context it is deployed in creates systematic failures:

Language mismatch. The majority of health facility staff in Cameroon work primarily in French. Many in the Anglophone regions work primarily in English. Software designed for a monolingual context — with only one language as an afterthought — creates friction at every interaction.

Currency and insurance incompatibility. International billing software is built around insurance systems — private insurance, Medicaid, Medicare, NHS — that do not exist in Cameroon. The CNPS (Caisse Nationale de Prévoyance Sociale) has its own claim formats, reporting requirements, and processing timelines that international platforms do not support.

Infrastructure assumptions. International platforms typically assume reliable electricity, broadband internet, and dedicated IT support. None of these can be taken for granted across Cameroon, particularly outside Douala and Yaoundé.

Support geography. When something breaks in an internationally hosted system, the nearest qualified support may be in Nairobi, Lagos, or London. Response times in hours — which matter in operational health environments — are simply unavailable.

Cost structures. International enterprise software is priced for international enterprise buyers. For a 20-bed private clinic in Bamenda operating in XAF, a software subscription denominated in dollars and priced for a Nigerian or Kenyan hospital is financially inaccessible.

The cumulative effect of these mismatches is that international health technology, even when genuinely well-intentioned and technically excellent, delivers a fraction of its potential value when deployed in the Cameroonian context.

Why Donor-Funded Technology Is Not the Answer Either

If commercial international technology is ill-fitted, surely donor-funded technology — built specifically for low-resource settings, often using open-source platforms — is the answer?

Partially. Donor-funded health technology has produced some of the most important digital health tools in use across Africa, including OpenMRS, DHIS2, and OpenLMIS. These platforms have transformed disease programme management and national health information systems across the continent, including in Cameroon.

But donor-funded technology has structural limitations that commercial technology does not:

Project cycles. Donor-funded technology is implemented through projects with defined timelines — typically three to five years. When the project ends, so does the funding for implementation support, training, maintenance, and updates. Systems that seemed sustainable during the project often degrade quickly after it ends.

Misaligned incentives. Donors are accountable to their home governments and boards, not to the Cameroonian health facilities using their platforms. When donor priorities shift — as they inevitably do — the platforms they fund shift with them, regardless of what Cameroonian users need.

Generic design. Open-source platforms designed to work across many countries inevitably make design compromises that serve no single country perfectly. The customisation required to make DHIS2 or OpenMRS work optimally in a specific Cameroonian context requires significant local technical capacity — which is often not available.

Dependency rather than capability. Donor-funded technology transfers tools to Cameroon but rarely builds the commercial ecosystem that would allow Cameroon to maintain, improve, and innovate on those tools independently. The result is ongoing dependency on external technical assistance rather than growing local capability.

What a Homegrown Health Tech Revolution Looks Like

A genuinely Cameroonian health tech revolution is not simply about building software in Cameroon instead of importing it. It is about building a sustainable ecosystem — companies, skills, infrastructure, and market relationships — that can continuously innovate and improve health technology for the Cameroonian context.

The core elements of this ecosystem:

Locally Founded and Owned Companies

Companies founded by Cameroonians, with local investors and local decision-making, have structural advantages over international subsidiaries and donor-funded projects. They face the same regulatory environment as their clients. Their teams understand the cultural and operational context of Cameroonian health facilities. They have reputations to maintain in the local market. And their commercial success depends on their clients' operational success — a powerfully aligning incentive.

OPES Health Systems exemplifies this model: a platform built from the ground up by a team with deep understanding of Cameroonian healthcare realities, commercially structured to be sustainable without ongoing donor support, and focused entirely on the CEMAC market.

Products Designed for Cameroonian Realities From Day One

Rather than adapting international platforms for Cameroon — a process that is always incomplete and always costly — homegrown platforms begin with Cameroonian realities as their design brief:

• Bilingual French-English interfaces as a baseline, not an add-on
• XAF-denominated pricing and billing
• CNPS and Cameroonian private insurer compatibility
• Offline-first architecture for low-connectivity environments
• Mobile interfaces for settings where tablets are more common than desktop computers
• Support structures that can reach any city in Cameroon

When the design brief is right, the product fits. When the product fits, adoption is faster, usage is higher, and the value delivered is greater.

Commercial Sustainability Through Client Value

The test of a health technology platform is not whether it can be funded by donors. It is whether health facilities will pay for it because it delivers more value than it costs. A homegrown health tech ecosystem must be built on this commercial logic — platforms that facilities adopt because they genuinely solve operational problems and generate a measurable return on investment.

This commercial sustainability is what makes a homegrown health tech ecosystem genuinely different from the donor-funded model: it does not depend on an external funding cycle. It depends on continued delivery of value to clients — which creates a powerful ongoing incentive to improve.

A Growing Local Talent Pool

A healthy health tech ecosystem requires developers, product managers, healthcare informatics specialists, implementation consultants, and support staff. Building this talent pool — through university programmes, training partnerships, and the learning-by-doing that comes from working in growing companies — is itself a long-term investment.

Each successful health tech company in Cameroon creates employment, trains talent, and grows the skills base from which the next generation of companies will emerge. This is how sustainable ecosystems are built.

The Economic Case: Health Tech as a Growth Sector

Beyond the healthcare benefits, a homegrown health tech ecosystem represents a significant economic opportunity for Cameroon.

The African health technology market is one of the fastest growing in the world. Venture capital investment in African health tech exceeded $500 million in 2023. The domestic Cameroonian market alone — nearly 30 million people, with a growing urban middle class, a dual public-private health system, and significant underserved healthcare needs — represents a substantial addressable market for health technology products.

Cameroon-based health tech companies that serve the domestic market are also positioned to expand across the CEMAC region — six countries sharing a common currency and a broadly similar health system context — and ultimately across francophone Africa.

The countries that build strong domestic health tech ecosystems today will be the ones that supply health technology to the rest of the continent tomorrow. Cameroon has the talent, the market, and the institutional environment to be one of those countries. But it requires deliberate investment and support.

What Government and Investors Can Do to Accelerate the Revolution

A homegrown health tech revolution does not happen spontaneously. It requires deliberate policy choices and investment.

Public procurement preferences. Giving preferential treatment to Cameroonian-built health technology platforms in public hospital procurement — similar to "Buy Cameroonian" policies in other sectors — would accelerate growth of the domestic ecosystem.

Tax incentives for health tech investment. Reducing corporate tax rates or providing R&D tax credits for health technology companies would increase the attractiveness of this sector for domestic and diaspora investors.

University and TVET health informatics programmes. Building health informatics into medical, nursing, and IT curricula would produce the talent that health tech companies need.

Regulatory sandboxes for health tech innovation. Creating protected regulatory environments where health tech companies can test new products — telemedicine platforms, diagnostic AI tools, remote monitoring devices — without full regulatory burden would accelerate innovation.

Patient capital. Early-stage health tech companies need patient capital — investment that understands the longer sales cycles of health system clients and does not demand returns within two years. Impact investors, development finance institutions, and diaspora investors are well-positioned to provide this.

Frequently Asked Questions

Why can't Cameroon just use African health tech platforms from Nigeria or Kenya? Nigerian and Kenyan platforms are better adapted to African contexts than international platforms, but they are primarily designed for anglophone markets and do not account for Cameroon's bilingual context, CNPS insurance system, or specific regulatory environment. Locally built Cameroonian platforms serve the context better.

How is OPES Health Systems different from international health software? OPES is designed from the ground up for the Cameroonian and CEMAC context — bilingual French-English interface, CNPS-compatible billing, XAF pricing, offline-first architecture, and CEMAC-region data hosting. It is not an international platform adapted for Cameroon; it is a Cameroonian platform.

Is the Cameroonian market large enough to sustain a domestic health tech ecosystem? Yes. Cameroon's approximately 30 million people, 2,000+ formal health facilities, and growing healthcare spending represent a substantial market. The CEMAC regional market — 60+ million people across six countries sharing a common currency — is even larger.

What is the biggest barrier to a homegrown health tech revolution in Cameroon? The biggest barrier is capital — specifically the patient, early-stage capital needed to fund health tech companies through the development and early commercialisation phases before they become self-sustaining. Addressing this through development finance, diaspora investment, and public funding mechanisms is the most important single intervention.

Conclusion: The Revolution Is Already Starting

The homegrown health tech revolution in Cameroon is not a distant aspiration. It is already beginning. Companies like OPES Health Systems are building products, winning clients, and demonstrating that Cameroonian-built health technology can compete with — and outperform — international alternatives in the Cameroonian context.

The question is whether this beginning becomes a sustained movement — supported by policy, investment, and talent development — or whether it remains isolated.

The opportunity is real. The need is urgent. The talent is here. What the moment requires is commitment: from investors, from policymakers, from hospitals and clinics willing to choose local, and from the entrepreneurs building the platforms.

The revolution is starting. It needs support to succeed.

OPES Health Systems is at the forefront of Cameroon's homegrown health tech revolution. Contact us to learn how we can support your facility's digital transformation.